{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:25:26Z","timestamp":1791037526307,"version":"4.1.0"},"reference-count":14,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,6,2]],"date-time":"2009-06-02T00:00:00Z","timestamp":1243900800000},"content-version":"vor","delay-in-days":121,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"name":"Pfizer Pharma GmbH, Berlin, Germany"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of the International AIDS Society"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:p>Interaction with the chemokine receptor, CCR5, is a necessary precondition for maintaining HIV\u20101 infection. Individuals with the CCR5\u2010delta32 deletion who lack this receptor are highly resistant to infection by the most common forms of HIV\u20101. We recently reported on the successful transplantation in an HIV\u20101\u2010positive patient of allogeneic stem cells homozygous for the CCR5\u2010delta32 allele, which stopped viral replication for more than 27 months without antiretroviral therapy.<\/jats:p><jats:p>Here, we report on the results of a meeting regarding the potential implications and future directions of stem cell\u2010targeted HIV treatments. The meeting drew together an international panel of hematologists, immunologists, HIV specialists and representatives from bone marrow donor registries.<\/jats:p><jats:p>The meeting came to an agreement to support further attempts to use CCR5\u2010delta32 deleted stem cells, for example, prescreened cord blood stem cells, to treat probable HIV\u20101\u2010positive patients with malignancies. Furthermore, improvement of HIV\u20101 therapy that interferes with the entry mechanism seems to be a promising approach in HIV\u20101\u2010infected patients with no matching CCR5\u2010delta32 deleted donor.<\/jats:p>","DOI":"10.1186\/1758-2652-12-10","type":"journal-article","created":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T06:13:57Z","timestamp":1246342437000},"page":"10-10","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Transplantation of selected or transgenic blood stem cells \u2013 a future treatment for HIV\/AIDS?"],"prefix":"10.1002","volume":"12","author":[{"given":"Gero","family":"H\u00fctter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0803152"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80110-5"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-10-199711150-00004"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802905"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61113-7"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1086\/527324"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.12.012"},{"issue":"12","key":"e_1_2_6_9_1","first-page":"1628","article-title":"CCR5 deletion mutation and its association with the risk of developing acute graft\u2010versus\u2010host disease after allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Bogunia\u2010Kubik K","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705703"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.2008\/003624-0"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-1348(02)00027-8"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.12.334"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","unstructured":"vonLaerD BaumC ProtzerU:Antiviral gene therapy.Handb Exp Pharmacol2009:265\u2013297.","DOI":"10.1007\/978-3-540-79086-0_10"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.sj.6300124"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1186%2F1758-2652-12-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1186\/1758-2652-12-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T16:45:01Z","timestamp":1696178701000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1186\/1758-2652-12-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1186\/1758-2652-12-10"],"URL":"https:\/\/doi.org\/10.1186\/1758-2652-12-10","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"2009-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-06-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-06-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}